CellCarta

CellCarta

Biotechnology-Research

Montreal, Quebec
Canada
Industry Category
Biotechnology-Research
Company Description

CellCarta stands as a global leader in precision medicine testing services, partnering with clients to overcome complex biomarker and bioanalytical challenges by delivering highly customized testing solutions. With facilities strategically located across Canada, the United States, Belgium, Australia, and China, CellCarta provides localized expertise to effectively support global clinical trials. The primary address of CellCarta is 141 Avenue du Président-Kennedy, Suite 5650, Montreal, Quebec H2X 1Y4, CA.

CellCarta offers access to seamlessly integrated analytical platforms encompassing immunology (immune monitoring), histopathology, proteomics, and genomics, in addition to digital pathology/AI and comprehensive sample management, logistics, and kitting services. CellCarta excels in assessing the immune system, bringing extensive expertise to oncology, infectious diseases, and autoimmune disorders. With a notable track record in other therapeutic areas, such as neurological and metabolic disorders, CellCarta adeptly handles diverse human biological specimens, deploying advanced technologies to extract valuable insights for research and diagnostic applications. The additional addresses include 201 Avenue du Président-Kennedy, Suite 3900, Montreal, Quebec H2X 3Y7, CA; 101 Ilsley Ave, Unit 5, Dartmouth, Nova Scotia B3B 1S8, CA; 1331 W 75th St, #401, Naperville, Illinois 60540, US; 80 Empire Drive, Lake Forest, California 92630, US; 8 rue Adrienne Bolland, 6041 GOSSELIES, BE; Sint-Bavostraat 78, Antwerp, Vlaanderen 2610, BE; Suite 4/54-60 Briggs Street, Camperdown, NSW 2050, AU; Lianhua Road No. 8, Information and Industrial Park, High-Tech Zone, Building 1, Floor 3, Jining, Shandong 272000, CN; and Technologiepark 82 B-9052, Zwijnaarde, BE.

Committed to quality, CellCarta maintains appropriate accreditations across its sites to support various regulatory requirements, including CAP, CLIA, ISO15189, ISO27001, and ISO13485. CellCarta delivers comprehensive assay development and testing services to support a wide range of translational research, clinical trials, and diagnostic applications. We invite the management team at CellCarta to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.

CellCarta se positionne comme un leader mondial dans les services de tests de médecine de précision, collaborant avec ses clients pour surmonter les défis complexes en matière de biomarqueurs et de bioanalyse en fournissant des solutions de tests hautement personnalisées. Avec des installations stratégiquement situées au Canada, aux États-Unis, en Belgique, en Australie et en Chine, CellCarta offre une expertise localisée pour soutenir efficacement les essais cliniques mondiaux. L'adresse principale de CellCarta est 141 Avenue du Président-Kennedy, Suite 5650, Montréal, Québec H2X 1Y4, CA.

CellCarta offre un accès à des plateformes analytiques intégrées de manière transparente, englobant l'immunologie (surveillance immunitaire), l'histopathologie, la protéomique et la génomique, en plus de la pathologie numérique/IA et des services complets de gestion des échantillons, de logistique et de constitution de kits. CellCarta excelle dans l'évaluation du système immunitaire, apportant une vaste expertise en oncologie, dans les maladies infectieuses et les troubles auto-immuns. Forte d'une expérience notable dans d'autres domaines thérapeutiques, tels que les troubles neurologiques et métaboliques, CellCarta manipule avec compétence divers échantillons biologiques humains, en déployant des technologies de pointe pour extraire des informations précieuses pour la recherche et les applications diagnostiques. Les adresses supplémentaires incluent 201 Avenue du Président-Kennedy, Suite 3900, Montréal, Québec H2X 3Y7, CA ; 101 Ilsley Ave, Unit 5, Dartmouth, Nouvelle-Écosse B3B 1S8, CA ; 1331 W 75th St, #401, Naperville, Illinois 60540, États-Unis ; 80 Empire Drive, Lake Forest, Californie 92630, États-Unis ; 8 rue Adrienne Bolland, 6041 GOSSELIES, BE ; Sint-Bavostraat 78, Anvers, Flandre 2610, BE ; Suite 4/54-60 Briggs Street, Camperdown, NSW 2050, AU ; Lianhua Road No. 8, Parc industriel et d'information, Zone de haute technologie, Bâtiment 1, Étage 3, Jining, Shandong 272000, CN ; et Technologiepark 82 B-9052, Zwijnaarde, BE.

Engagée envers la qualité, CellCarta maintient les accréditations appropriées sur ses sites pour soutenir diverses exigences réglementaires, notamment CAP, CLIA, ISO15189, ISO27001 et ISO13485. CellCarta fournit des services complets de développement et de tests d'essais pour soutenir un large éventail de recherches translationnelles, d'essais cliniques et d'applications diagnostiques. Nous invitons l'équipe de direction de CellCarta à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer davantage votre présence sur le marché.

Key Personnel / Employees
Martin LeBlanc Mark Watson Christopher Ung Anna-Maria Leoci

Compare Companies Side by Side

Compare CellCarta with 3 companies in Biotechnology-Research

4 Companies
Comparison Field
CellCarta
CellCarta
Main Company
Cell Signaling Technology (CST)
Cell Signaling Techn...
View Profile
Drug Discovery & Development
Drug Discovery & Dev...
View Profile
KYAN Technologies
KYAN Technologies
View Profile
Founded Year
1999 0 2016
Company Size
501-1,000 51-200 2-10
City
Montreal, Quebec Danvers, MA Cleveland, Ohio
Country
Canada United States United States
Skills & Keywords Comparing with main company
34 Total Skills
Precision Medicine Biomarker Analysis Clinical Trials Immune Monitoring Histopathology Proteomics Genomics Mass Cytometry Auto-Immune Diseases Kitting Sample Logistics Biotechnology Biologics Mass Spectrometry Pathology Molecular Techniques Bioinformatics Fluorescence in situ hybridization Immunohistochemistry Immunology CRO Laboratory Oncology Infectious Diseases Neurological & Metabolic Disorders Biomarker Flow Cytometry ELISpot Neo-Epitope Discovery Sample Procurement Tissue Analysis Tumor Profiling Personalized Medicine Immunofluorescence Pharmaceuticals
10 Total 10 Unique
Unique Skills:
Cell Biology Chromatin Immunoprecipitation Development Gene Expression Growth & Viability Immunoprecipitation +4
43 Total 1 Common 42 Unique
Match 3%
Common Skills:
Clinical Trials
Unique Skills:
Artificial Intelligence Big Pharma BioPharma Biopharmaceuticals BioTech Contract Research Organizations +36
5 Total 5 Unique
Unique Skills:
Clinical Development Digital Healthcare Dosage Optimization Drug Development Licensing/Distribution
4
Total Companies
1999
Oldest Founded
2
Countries
90
Unique Skills

Similar Companies

Other organizations in the same industry

PreventiGene
Biotechnology-Research

The Next Generation Health Method

Fractyl Health
Biotechnology-Research

Dedicated to novel therapeutic interventions that can reverse the metabolic disease epidemic.

Lexington, MA
United States
Facet Biotech
Biotechnology-Research
Phenomenex
Biotechnology-Research

Enabling scientists inside the lab to create a better world outside.

Torrance, CA
United States

Alternative Company Names

This company is also known as

CellCarta 赛尔卡塔 सेलकार्टा سيلكارتا СеллКарта